Searchable abstracts of presentations at key conferences in endocrinology

ea0016p718 | Thyroid | ECE2008

Hypothyroidism after transarterial chemoembolization for hepatocellular carcinoma

Flohr Felix , Harder Jan , Seufert Jochen

Transarterial chemoembolization (TACE) is widely used for treatment of hepatocellular carcinoma (HCC). During this procedure approximately 20 g of iodide is applied by radiopaque material. There is usually high awareness regarding hyperthyroidism in association with contrast enhanced imaging studies and TACE. To date, however, there are no reports regarding the frequency of hypothyroidism after this procedure, although high doses of iodide can also inhibit the synthesis of thy...